Siena, Italy

Giulio Ratti

This inventor holds 19 USPTO granted patents and 8 published patent applications and 9 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Novartis Vaccines & Diagnostics, Gmbh, Novartis Vaccines and Diagnostics Srl. Active years: 1992-2016.

USPTO Granted Patents = 19 

% Patents Active = 26.3

 

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 226(Granted Patents)


Company Filing History:


Years Active: 1992-2016

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Giulio Ratti: Innovator in Vaccine Development

Introduction

Giulio Ratti is a prominent inventor based in Siena, Italy. He has made significant contributions to the field of vaccine development, holding a total of 19 patents. His work focuses on proteins that are predicted to be useful antigens for vaccines and diagnostics.

Latest Patents

Among his latest patents, Giulio Ratti has developed inventions that provide proteins, including the amino acid sequences and the corresponding nucleotide sequences. These proteins are anticipated to play a crucial role in the development of effective vaccines and diagnostic tools.

Career Highlights

Giulio Ratti has worked with notable companies in the pharmaceutical industry, including GlaxoSmithKline Biologicals and Novartis Vaccines and Diagnostics. His experience in these organizations has allowed him to contribute to groundbreaking advancements in vaccine technology.

Collaborations

Throughout his career, Giulio has collaborated with esteemed colleagues such as Guido Grandi and Vega Masignani. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Giulio Ratti's contributions to vaccine development and his extensive patent portfolio highlight his role as a key innovator in the industry. His work continues to impact the field of immunology and diagnostics significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…